Trans Tasman Radiation Oncology Group (TROG) [ 2005 - 2011 ]

Research Grant

Researchers: Prof David Ball (Principal investigator) ,  Dr Peter O'Brien ,  Prof Bryan Burmeister ,  Prof David Joseph ,  Prof Gillian Duchesne
View all 6 related researchers

Brief description The Trans Tasman Radiation Oncology Group is an experienced research group conducting cancer clinical trials involving radiotherapy (RT) in order to improve cure rates, quality of life and to reduce side-effects of treatment. Fifty per cent of all cancer patients need RT as part of their treatment. The aim of the proposal is to strengthen the quality and safety of RT trials by (a) enabling rapid review and checking of treatment by electronic means and (b) improve trial design.

Funding Amount $AUD 1,769,500.00

Funding Scheme NHMRC Enabling Grants

Notes Clinical Trials Resources